INVIVO EFFECTS OF LR5182, CIS-3-(3,4-DICHLOROPHENYL)-2-N,N-DIMETHYLAMINOMETHYL-BICYCLO-[2,2,2]-OCTANE HYDROCHLORIDE, AN INHIBITOR OF UPTAKE INTO DOPAMINE AND NOREPINEPHRINE NEURONS

被引:3
作者
FULLER, RW
PERRY, KW
SNODDY, HD
机构
[1] The Lilly Research Laboratories. Eli Lilly and Company, Indianapolis
关键词
cis-3-(3,4-dichlorophenyl)-2-N,N-dimethylaminomethylbicyclo-[2,2,2]-octane; dopamine uptake inhibition; LR5182; metaraminol; norepinephrine uptake inhibition; 6-hydroxydopamine; α-methyl-m-tyramine; α-methyl-m-tyrosine;
D O I
10.1016/0028-3908(79)90076-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
cis-3-(3,4-Dichlorophenyl)-2-N,N-dimethylaminomethyl-bicyclo-[2,2,2]-octane hydrochloride, (LR5182) antagonized the depletion of heart norepinephrine by 6-hydroxydopamine but not the depletion of brain serotonin by p-chloroamphetamine in mice. Norepinephrine depletion was antagonized by LR5182 following α-methyl-m-tyrosine injection into rats both in the cerebral hemispheres and in the hypothalamus. The drug also antagonized dopamine depletion in the cerebral hemispheres but did not antagonize epinephrine depletion in the hypothalamus in these rats. The concentration of α-methyl-m-tyramine and of metaraminol in the cerebral hemispheres of rats was lowered by LR5182 after α-methyl-m-tyrosine injection; since these amine metabolites are taken up and retained by dopamine and norepinephrine neurons, respectively, this lowering is a further indication of the inhibition of uptake into dopamine and norepinephrine neurons by LR5182. The elevation of brain DOPAC (3,4-dihydroxyphenylacetic acid) was significantly enhanced by LR5182 following spiperone injection, an effect characteristic of a particular subclass of dopamine uptake inhibitors. © 1979.
引用
收藏
页码:497 / 501
页数:5
相关论文
共 15 条
[1]   BIOCHEMICAL DIFFERENTIATION OF AMPHETAMINE VS METHYLPHENIDATE AND NOMIFENSINE IN RATS [J].
BRAESTRUP, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (08) :463-470
[2]   COMPARATIVE EFFECTS OF PEMOLINE, AMFONELIC ACID AND AMPHETAMINE ON DOPAMINE UPTAKE AND RELEASE INVITRO AND ON BRAIN 3,4-DIHYDROXYPHENYLACETIC ACID CONCENTRATION IN SPIPERONE-TREATED RATS [J].
FULLER, RW ;
PERRY, KW ;
BYMASTER, FP ;
WONG, DT .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (03) :197-198
[3]  
FULLER RW, 1975, PSYCHOPHARMACOL COMM, V1, P455
[4]   LOWERING OF EPINEPHRINE CONCENTRATION IN RAT-BRAIN BY 2,3-DICHLORO-ALPHA-METHYL-BENZYLAMINE, AN INHIBITOR OF NOREPINEPHRINE N-METHYLTRANSFERASE [J].
FULLER, RW ;
PERRY, KW .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (21) :2087-2090
[5]   EFFECT OF LERGOTRILE ON 3,4-DIHYDROXYPHENYLACETIC ACID (DOPAC) CONCENTRATION AND DOPAMINE TURNOVER IN RAT-BRAIN [J].
FULLER, RW ;
PERRY, KW .
JOURNAL OF NEURAL TRANSMISSION, 1978, 42 (01) :23-35
[6]  
FULLER RW, J NEURAL T
[7]  
MILLER F P, 1970, Biochemical Pharmacology, V19, P435, DOI 10.1016/0006-2952(70)90199-1
[8]   EFFECT OF TROPOLONE ON FORMATION OF 3,4-DIHYDROXYPHENYLACETIC ACID AND 4-HYDROXY-3-METHOXYPHENYLACETIC ACID IN BRAIN OF MOUSE [J].
MURPHY, GF ;
ROBINSON, D ;
SHARMAN, DF .
BRITISH JOURNAL OF PHARMACOLOGY, 1969, 36 (01) :107-&
[9]  
PERRY KW, 1977, 6TH ANN M SOC NEUR
[10]  
PERRY KW, 1978, 8TH ANN M SOC NEUR